Backed by $21M from investors, Raleigh-based Innovate Biopharmaceuticals becomes public company
Innovate Biopharmaceuticals, a clinical stage biotechnology company focused on developing novel autoimmune and inflammation therapeutics, has completed its reverse merger with California-based Monster Digital and is now a publicly traded company
Read More
